Evidence map›Paper›PMID 33305733›Full record

ArticleeLife2020

The leukocyte non-coding RNA landscape in critically ill patients with sepsis.

Brendon P Scicluna, Fabrice Uhel, Lonneke A van Vught, Maryse A Wiewel, Arie J Hoogendijk, Ingelore Baessman, Marek Franitza, Peter Nürnberg, Janneke Horn, Olaf L Cremer and 4 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Brendon P SciclunaAmsterdam UMC, University of Amsterdam, Center for Experimental Molecular Medicine, Amsterdam Infection & Immunity, Amsterdam, Netherlands.ORCID 0000-0003-2826-0341
Fabrice UhelAmsterdam UMC, University of Amsterdam, Center for Experimental Molecular Medicine, Amsterdam Infection & Immunity, Amsterdam, Netherlands.ORCID 0000-0003-4946-8184
Lonneke A van VughtAmsterdam UMC, University of Amsterdam, Center for Experimental Molecular Medicine, Amsterdam Infection & Immunity, Amsterdam, Netherlands.
Maryse A WiewelAmsterdam UMC, University of Amsterdam, Center for Experimental Molecular Medicine, Amsterdam Infection & Immunity, Amsterdam, Netherlands.
Arie J HoogendijkAmsterdam UMC, University of Amsterdam, Center for Experimental Molecular Medicine, Amsterdam Infection & Immunity, Amsterdam, Netherlands.
Ingelore BaessmanCologne Center for Genomics, University of Cologne, Cologne, Germany.
Marek FranitzaCologne Center for Genomics, University of Cologne, Cologne, Germany.
Peter NürnbergCologne Center for Genomics, University of Cologne, Cologne, Germany.
Janneke HornAmsterdam UMC, University of Amsterdam, Department of Intensive Care Medicine, Amsterdam, Netherlands.
Olaf L CremerDepartment of Intensive Care, University Medical Center Utrecht, Utrecht, Netherlands.
Marc J BontenDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands.
Marcus J SchultzAmsterdam UMC, University of Amsterdam, Department of Intensive Care Medicine, Amsterdam, Netherlands.
Tom van der PollAmsterdam UMC, University of Amsterdam, Center for Experimental Molecular Medicine, Amsterdam Infection & Immunity, Amsterdam, Netherlands.
Molecular Diagnosis and Risk Stratification in Sepsis (MARS) consortium
Amsterdam University Medical Centers · NLUniversity of Cologne · DEUniversity Medical Center Utrecht · NL

Funding

Center for Translational Molecular Medicine 04I-201Innovative Medicines Initiative Joint Undertaking 115523Innovative Medicines Initiative Joint Undertaking 115620Innovative Medicines Initiative Joint Undertaking 115737
6 · The paper itself

Abstract

The extent of non-coding RNA alterations in patients with sepsis and their relationship to clinical characteristics, soluble mediators of the host response to infection, as well as an advocated in vivo model of acute systemic inflammation is unknown. Here we obtained whole blood from 156 patients with sepsis and 82 healthy subjects among whom eight were challenged with lipopolysaccharide in a clinically controlled setting (human endotoxemia). Via next-generation microarray analysis of leukocyte RNA we found that long non-coding RNA and, to a lesser extent, small non-coding RNA were significantly altered in sepsis relative to health. Long non-coding RNA expression, but not small non-coding RNA, was largely recapitulated in human endotoxemia. Integrating RNA profiles and plasma protein levels revealed known as well as previously unobserved pathways, including non-sensory olfactory receptor activity. We provide a benchmark dissection of the blood leukocyte 'regulome' that can facilitate prioritization of future functional studies.

Indexed as

Critical IllnessAgedCase-Control StudiesEndotoxemiaFemaleHumansLeukocytesMaleMiddle AgedOligonucleotide Array Sequence AnalysisRNA, UntranslatedSepsisTranscriptomeRNA, Untranslatedhumanimmunologyinflammationleukocytenon-coding RNAsepsis

Identifiers

PMID33305733
PMCPMC7775110
OpenAlexW3113297007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.